California Cancer Reporting System Standards, Volume III
Eureka Hospital Transmit
Eureka Tumor Level
Eureka Admission Level
Behavior Code ICD-0-3 [NAACCR #523]
CS Extension [NAACCR #2810]
CS Site Specific Factor 1 [NAACCR #2880]
CS Site Specific Factor 25 [NAACCR #2879]
Histologic Type ICD-0-3 [NAACCR #522]
Primary Site [NAACCR #400]
If CS Extension = 000, CS Site Specific Factor 1 must = 987.
This edit verifies that if CS Extension indicates a non-invasive lesion, then CS Site-Specific Factor 1 (FIGO Stage) is coded consistently for Cervix, CorpusAdenosarcoma, CorpusCarcinoma,CorpusSarcoma, FallopianTube, Vagina, and Vulva schemas.
This edit first determines the correct CS schema by doing a function call to the CS Dynamic Link Library (dll). The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.
This edit is skipped if any of the following conditions are true:
CS Site-Specific Factor 1 is blank or = 988
CS Extension is blank
Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
CS schema is invalid
If CS schema is Cervix, CorpusAdenosarcoma, CorpusCarcinoma, CorpusSarcoma, FallopianTube, Vagina, or Vulva:
If CS Extension = 000 (In situ, intraepithelial, noninvasive, preinvasive), then CS Site-Specific 1 must = 987 [Carcinoma in situ (intraepithelial, noninvasive, preinvasive)]
Historical Changes
In the SEER*Edits software, the title of this edit is: IF357
| 7/27/11 | New edit for NAACCR 12.1.A. |
| 04/2014 | Function call to the CS Dynamic Link Library updated to call "CStage0205.dll" instead of "CStage.dll." |